MAZE
Maze Therapeutics, Inc. Common Stock
NASDAQ: MAZE · HEALTHCARE · BIOTECHNOLOGY
$26.58
+3.50% today
Updated 2026-04-30
Market cap
$1.42B
P/E ratio
—
P/S ratio
501.65x
EPS (TTM)
$-3.05
Dividend yield
—
52W range
$8 – $54
Volume
0.9M
Maze Therapeutics, Inc. Common Stock (MAZE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-47.50%
ROA
-28.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | $0.00 | $-114.94M | — | — | — |
| 2023 | $0.00 | $-100.42M | — | — | — |
| 2024 | $167.50M | $52.23M | 100.00% | 34.38% | 31.18% |
| 2025 | $0.00 | $-131.12M | — | — | — |